JPRN-UMIN000004056招募中2 期
Mizollibin Therapy for Pigmented Villonodular Synovitis or Giant cell tumor of tendon sheath - MTPVNS
Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University0 个研究点目标入组 15 人开始时间: 2010年8月17日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Past history of mizollibin sensitivity WBC count<3,000/mm3 Pregnant women
研究者
相似试验
终止
4 期
Brolucizumab Treatment For Pigment Epithelial Detachment In Treatment-Resistant Neovascular Age Related Macular DegeneratioAge related macular degenerationEye - Diseases / disorders of the eyeACTRN12621000305820Sydney Retina Clinic & Day Surgery10
尚未招募
3 期
Phototherapy with topical minoxidil in vitiligo:A Randomised control trialCTRI/2023/10/059079Sejal Bajoria
进行中（未招募）
1 期
Ipilimumab and Nivolumab in patients with malignant Pleural Mesothelioma: INITIATEMedDRA version: 19.0Level: LLTClassification code 10027408Term: Mesothelioma malignant advancedSystem Organ Class: 100000004864Malignant pleural mesotheliomaEUCTR2016-001599-31-NLStichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis
已完成
2 期
Ipilimumab and Nivolumab in the Treatment of malignant Pleural Mesothelioma: a Phase II study10027412pleural mesotheliomaNL-OMON46045Antoni van Leeuwenhoek Ziekenhuis33
已完成
2 期
Riluzole in the treatment of major depressioMajor Depressive episode.Major Depressive episodeIRCT201307181556N54Tehran University of Medical Sciences40